{"url_path":"/sec/mnpr/8-k/2026-07-22/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits.**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-07-22","source_url":"https://www.sec.gov/Archives/edgar/data/1645469/0001437749-26-024041-index.html","accession_number":"0001437749-26-024041","cik":"0001645469","ticker":"MNPR","issuer_name":"Monopar Therapeutics","edgar_url":"https://www.sec.gov/Archives/edgar/data/1645469/0001437749-26-024041-index.html","primary_entity_key":"0001645469","primary_entity_name":"Monopar Therapeutics"},"word_count":86,"has_tables":true,"body_markdown":"**Item 9.01 Financial Statements and Exhibits.**\n\n \n\n \n\n(d)\n\nExhibits.\n\n \n\n**Exhibit**\n\n**No.** \n\n \n\n**Description**\n\n99.1\n\n \n\n[Press Release Dated July 22, 2026.](ex_991049.htm)\n\n104\n\n \n\nCover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document.\n\n \n\n \n\n**SIGNATURE**\n\n \n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\n \n\n \n\n**Monopar Therapeutics Inc.**\n\n \n\n \n\n \n\n \n\n \n\nDate: July 22, 2026\n\nBy:\n\n/s/ Quan Vu\n\n \n\n \n\nName:\n\nQuan Vu\n\n \n\n \n\nTitle:\n\nChief Financial Officer"}